In a preliminary study by Hall et al (1998), germline mutations in ATM were identified in three out of 17 (17.6%) prostate cancer patients who showed a severe late response to radiation therapy and in whom most or all of the ATM gene was examined, while no such mutations were found in the control group. This evidence concerns the gene ATM and prostate carcinoma.